posted by Phill Allen
July, 09th, 2014
Company News Pharmaceutical Industry News
Biomanufacturing professionals have pinpointed improved flexibility and increased ROI as key drivers behind why they are making the move to single-use systems.
The findings come as part of a comprehensive online survey carried out by Pharma IQ who generated feedback from stakeholders around the world.
According to the survey, single-use and disposable technologies have been gaining momentum in the biopharmaceuticals industry over the past decade.
Key drivers behind this, include:
- 81% of respondents cited improved flexibility
- 30% of respondents cited reduced time to market
- 23% of respondents cited increased ROI
- 64% of respondents cited reduced cross-contamination issues
The report says that whilst the advantages of single-use technology are clear, the market is yet to reach maturity. This is partially down to the fact that the industry remains unclear on standards and regulatory guidance.
Visit for more information
Related reading:
TAGS:
Biopharmaceutical, single-use systems,
SHARE:
Author
Phill Allen
Managing Director
Phill is an innovative thinker particularly in fluid management. His expertise lies in ensuring the seamless flow of pharmaceutical liquid logistics, whether it's optimising current processes or pioneering new approaches.